{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:50:17Z","timestamp":1788274217624,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["22-076"],"award-info":[{"award-number":["22-076"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["2022\/SCOTT\/13545"],"award-info":[{"award-number":["2022\/SCOTT\/13545"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["13536"],"award-info":[{"award-number":["13536"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022513","name":"Tasmanian Department of Health","doi-asserted-by":"publisher","award":["TT55-0335 (2988)"],"award-info":[{"award-number":["TT55-0335 (2988)"]}],"id":[{"id":"10.13039\/501100022513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pnpbp.2026.111645","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:22:18Z","timestamp":1771374138000},"page":"111645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial"],"prefix":"10.1016","volume":"145","author":[{"given":"Dimitri","family":"Daldegan-Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina Joy","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Sumner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hee","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Alshakhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hoeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Sundram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Menkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Muthukumaraswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2026.111645_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2026.111645_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","author":"APA","year":"2022"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111645_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0447.2008.01289.x","article-title":"A validation analysis of two self-reported HAM-D6 versions","volume":"119","author":"Bech","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111645_bb0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","article-title":"Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers","volume":"86","author":"Bershad","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111645_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-024-08384-3","article-title":"LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder","volume":"25","author":"Daldegan-Bueno","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.pnpbp.2026.111645_bb0030","article-title":"LSD microdosing in major depressive disorder: results from an open-label trial","author":"Daldegan-Bueno","year":"2025","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111645_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40814-023-01399-8","article-title":"An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)","volume":"9","author":"Donegan","year":"2023","journal-title":"Pilot Feasibility Stud."},{"key":"10.1016\/j.pnpbp.2026.111645_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110670","article-title":"Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: identifying the need for psychedelic expectancy measures","author":"Donegan","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111645_bb0045","series-title":"What is it like to Microdose LSD for Depression? A Thematic Analysis of Participant Interviews from an Open-Label Trial","author":"Donegan","year":"2025"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111645_bb0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111645_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"9","author":"GBD","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111645_bb0060","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cpt.2057","article-title":"Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide microdoses in healthy participants","volume":"109","author":"Holze","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111645_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","article-title":"Mood and cognition after administration of low LSD doses in healthy volunteers: a placebo controlled dose-effect finding study","volume":"41","author":"Hutten","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111645_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis","volume":"322","author":"Ko","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111645_bb0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0269881119857204","article-title":"Microdosing psychedelics: more questions than answers? An overview and suggestions for future research","volume":"33","author":"Kuypers","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111645_bb0080","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111645_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02791072.2019.1683260","article-title":"Psychedelic microdosing: a subreddit analysis","volume":"52","author":"Lea","year":"2020","journal-title":"J. Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111645_bb0090","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-020-05477-0","article-title":"Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders","volume":"237","author":"Lea","year":"2020","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111645_bb0095","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41386-023-01772-4","article-title":"Greater subjective effects of a low dose of LSD in participants with depressed mood","volume":"49","author":"Molla","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"0","key":"10.1016\/j.pnpbp.2026.111645_bb0100","article-title":"Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers","volume":"0","author":"Morse","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111645_bb0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biopsych.2023.03.013","article-title":"Acute mood-elevating properties of microdosed lysergic acid diethylamide in healthy volunteers: a home-administered randomized controlled trial","volume":"94","author":"Murphy","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111645_bb0110","article-title":"Microdosing psychedelics: current evidence from controlled studies","author":"Murphy","year":"2024","journal-title":"Biol. Psychiatry: Cognit. Neurosci. Neuroimaging"},{"key":"10.1016\/j.pnpbp.2026.111645_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104706","article-title":"The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955\u20132021) and recommendations for the field","volume":"139","author":"Polito","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111645_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.9758\/cpn.23.1086","article-title":"Anhedonia and depressive disorders","volume":"21","author":"Serretti","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111645_bb0125","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.5664\/jcsm.7478","article-title":"A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression","volume":"14","author":"Snyder","year":"2018","journal-title":"J. Clin. Sleep Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111645_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90343-y","article-title":"Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis","volume":"11","author":"Vizeli","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111645_bb0135","series-title":"Depressive Disorder (Depression)","author":"WHO","year":"2023"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111645_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.106.032532","article-title":"Development and reliability of a structured interview guide for the Montgomery-\u00c5sberg depression rating scale (SIGMA)","volume":"192","author":"Williams","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111645_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115886","article-title":"Efficacy and safety of psychedelics for the treatment of mental disorders: a systematic review and meta-analysis","volume":"335","author":"Yao","year":"2024","journal-title":"Psychiatry Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:36:37Z","timestamp":1778538997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S0278584626000412"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111645","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111645"}}